More work needed to advance drug design and development effectively.
Ronak Savla
Advertisement
Ronak Savla is scientific affairs manager at Catalent Pharma Solutions.
Articles by Ronak Savla
Macromolecular drugs are typically injected, but oral dosage forms are being developed to improve the treatment of gastrointestinal conditions such as inflammatory bowel disease.
Formulation expertise can smooth the transition of a prospective therapy from medicinal chemistry to drug dosage form.
Advertisement
Latest Updated Articles
Bridging the Gap from Molecule to DrugPublished: April 2nd 2018 | Updated:
Oral Delivery of Macromolecular DrugsPublished: July 2nd 2018 | Updated:
- Pulling Together to Advance Patient-Focused Drug Products
Published: April 2nd 2019 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Everything to Know About Pharmaceutical Tariffs in 2025
2
Behind the Headlines Episode 28: Navigating FDA Shakeups and Obesity Drug Wars
3
Challenges for the Global Manufacturing of Vaccines
4
Building Resilience in Pharma: Our Top 10 Questions from CPHI Frankfurt
5
